Acutaas Chemicals Limited announces Q2 and H1 FY2027 unaudited financial results
Acutaas Chemicals Ltd · Pharmaceuticals & Biotechnology
What the filing says
- Consolidated profit before tax for the half year ended September 30, 2026 was Rs. 27,127.19 lakhs, against Rs. 15,425.55 lakhs for the half year ended September 30, 2025
- Consolidated net cash generated by operating activities for the half year ended September 30, 2026 was Rs. 21,591.90 lakhs; purchase of PPE, CWIP and intangibles was Rs. 12,392.04 lakhs
- Board approved the results on October 27, 2026; Maheshwari & Co's limited review reports on standalone and consolidated results have no modification
Why it's rated major development: the year-on-year change is 86% (50% or more)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other financial results filings this fortnight
- Juniper Green Energy Limited announces unaudited Q2 and H1 FY2027 financial results
- Andhra Paper Limited reports Q2 and H1 FY 2027 unaudited financial results
- Advait Energy Transitions approves Sept 2026 quarter results and AURA stake purchase
- Medi Assist Healthcare Services Limited approves results and share buyback
- RattanIndia Power approves unaudited Q2 and H1 results to September 30, 2026
- Network18 Media & Investments Ltd reports Q2 & H1 FY2026 unaudited financial results
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.